Status:
COMPLETED
Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test
Lead Sponsor:
National Institute for Tuberculosis and Lung Diseases, Poland
Collaborating Sponsors:
The Regional Public Hospital in Lesko, Poland
University of Rzeszow
Conditions:
Asthma in Children
Eligibility:
All Genders
7-15 years
Phase:
NA
Brief Summary
The aim of the study is to assess the usefulness of the indirect bronchial hyperresponsiveness test (with hypertonic NaCl) in determining the optimal dose of inhaled steroids to maintain asthma contro...
Eligibility Criteria
Inclusion
- mild asthma with a stable course of at least 3 months
- good adherence to treatment with low dose ICS
Exclusion
- infection or exacerbation of asthma requiring the use of systemic steroids (or changes in the dose of inhaled steroids) in the last 3 months before the study
- other chronic lung diseases or general diseases affecting the respiratory system
- tobacco smoking
- FEV1 below 80% of the predicted value
Key Trial Info
Start Date :
July 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04509921
Start Date
July 2 2018
End Date
August 30 2019
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Regional Public Hospital in Lesko, Poland
Lesko, Poland, 38-600